Activating Cancer-Killing Immune Cells
Complete the form below to unlock access to ALL audio articles.
Cancer cells are very adaptive - they exploit this switch to hide from the immune system and avoid attack. Now researchers have shown that it is possible to use genetic editing to snip away the ‘off switch’ so that the immune system recognises cancer again.
The team used a cutting-edge gene editing technique to remove the switch - called PD-1* - from T cells found in the tumour. They found that the immune system was then able to wipe out the cancer cells which no longer had control over the T cells.
Researchers refer to this as ‘cutting the brakes’ and allowing immune cells to do the rest.
The study was carried out on mice in the laboratory. The researchers took T cells from the tumour, removed PD-1, multiplied the T cells and put them back into the mice and found that the tumours shrank. In experiments on melanoma and fibrosarcoma, mouse survival increased from less than 20% after 60 days without treatment to more than 70% with treatment.
Going forward, the next step will be to test this approach in clinical trials.
Dr Sergio Quezada, Head of the Immune Regulation and Cancer Immunotherapy lab at UCL Cancer Institute says: "This is an exciting discovery and means we may have a way to get around cancer's defences while only targeting the immune cells that recognise the cancer.
"While drugs that block PD-1 do show promise, this method only knocks out PD-1 on the T cells that can find the tumour - which could mean fewer side effects for patients."
*The PD-1 switch – found on T cells – is normally a safety device that stops the immune cells from wrongly attacking harmless cells.